Wegovy

Wegovy (Semaglutide) is a prescription medication for weight management and should only be used under the supervision of a healthcare provider. It is not suitable for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Common side effects include nausea, vomiting, diarrhea, and abdominal pain. Do not use Wegovy if you are pregnant or breastfeeding. Always consult your healthcare provider before starting Wegovy to ensure it is appropriate for your health needs.

1. Consult Your Healthcare Provider: Ensure Wegovy is right for you and obtain a prescription.
2. Preparation: Store Wegovy in the refrigerator. Allow the pen to reach room temperature before use.
3. Administration: Administer Wegovy once weekly using the pre-filled injection pen. Inject into the abdomen, thigh, or upper arm, rotating sites each week.
4. Follow Instructions: Follow the specific instructions provided with the pen for accurate dosing.
5. Missed Dose: If you miss a dose, take it as soon as possible within 5 days of the missed dose. If more than 5 days have passed, skip the missed dose and resume your regular schedule. Do not double the dose.
6. Storage: Store unused pens in the refrigerator. Once in use, pens can be kept at room temperature for up to 4 weeks.

Always follow your healthcare provider’s instructions and refer to the medication guide for detailed information.

Active Ingredient:

• Semaglutide: A GLP-1 receptor agonist used for weight management in adults with obesity or overweight conditions.

Inactive Ingredients:

• Disodium Phosphate Dihydrate: A buffering agent that helps maintain the stability and pH of the solution.
• Sodium Chloride: Maintains the appropriate salt balance in the solution.
• Hydrochloric Acid (for pH adjustment): Used to adjust the acidity of the solution.
• Sodium Hydroxide (for pH adjustment): Also used to balance the solution’s pH.
• Water for Injection: Sterile water used as a solvent to dissolve the active and inactive ingredients.

These ingredients combine to form a stable, effective injectable solution for weight management. Always refer to the medication guide for the most detailed and specific information.

Common Side Effects:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain

Less Common Side Effects:

• Indigestion
• Fatigue
• Dizziness
• Bloating
• Belching
• Gas

Serious Side Effects:

• Severe allergic reactions (e.g., rash, itching/swelling, severe dizziness, trouble breathing)
• Pancreatitis (symptoms include severe stomach/abdominal pain, persistent nausea/vomiting)
• Gallbladder problems (e.g., gallstones, cholecystitis, symptoms include severe stomach pain, yellowing eyes/skin)
• Kidney problems (e.g., changes in urine output)
• Increased heart rate

Note: This is not a complete list of possible side effects. If you experience any unusual symptoms or side effects, contact your healthcare provider immediately. Always consult your healthcare provider for more detailed information and guidance tailored to your specific health needs.

1. What is Wegovy (Semaglutide)? Wegovy is a prescription medication designed to help adults with obesity or overweight individuals with weight-related health conditions achieve and maintain weight loss. It works by mimicking the GLP-1 hormone, which helps regulate appetite and food intake.

2. How is Wegovy administered? Wegovy is administered once weekly via a pre-filled injection pen. The injection is typically given in the abdomen, thigh, or upper arm. Your healthcare provider will provide detailed instructions on how to properly use the pen.

3. What are the common side effects of Wegovy? Common side effects of Wegovy may include nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects often decrease over time as your body adjusts to the medication. Consult your healthcare provider if any side effects persist or become bothersome.

4. Who should not use Wegovy? Wegovy is not suitable for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It is also not recommended for those who are pregnant or breastfeeding. Always consult your healthcare provider to determine if Wegovy is appropriate for you.

5. How soon can I expect to see results with Wegovy? Individual results may vary, but many patients start to see significant weight loss within a few weeks of starting Wegovy, especially when combined with a reduced-calorie diet and increased physical activity. Your healthcare provider can provide more specific guidance based on your treatment plan.